Feb 7 (Reuters) - Aurobindo Pharma Ltd, India’s third largest drugmaker by revenue, posted an about 3 percent rise in quarterly profit on Wednesday, but missed analysts’ estimates.
Profit was 5.95 billion rupees ($92.6 million) in the third quarter ended Dec. 31, compared with 5.79 billion rupees a year earlier, the Hyderabad-headquartered drugmaker said. bit.ly/2FSPsfo
Analysts on average had expected a profit of 6.71 billion rupees, Thomson Reuters data showed.
Total revenue from operations rose 11 percent to 43.36 billion rupees.
$1 = 64.2600 Indian rupees Reporting by Jessica Kuruthukulangara and Aby Jose Koilparambil in Bengaluru; Editing by Amrutha Gayathri